AtriCure Inc (ATRC):企業の財務・戦略的SWOT分析

◆英語タイトル:AtriCure Inc (ATRC) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15756
◆発行会社(調査会社):GlobalData
◆発行日:2019年4月
◆ページ数:47
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

AtriCure Inc (ATRC) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

AtriCure, Inc. (AtriCure) is a provider of medical devices for the treatment of atrial fibrillation (Afib) and related conditions. The company carries out the development, manufacture and sale of cardiac surgical ablation devices. Its major products include Isolator Synergy ablation system, a bipolar ablation clamp system; radio frequency ablation devices; cryoICE cryoablation system and AtriClip left atrial appendage (LAA) exclusion system. It also offers Lumitip dissectors and reusable cardiac surgery instruments. The company markets and sells its products in markets outside the US through its European subsidiaries and independent distributors. It has distributors in Asia Pacific, North America, South America, Europe, the Middle East, and Africa. AtriCure is headquartered in Mason, Ohio, the US.

AtriCure Inc Key Recent Developments

Feb 28,2019 AtriCure reports fourth quarter and full year 2018 financial results
Jan 07,2019 AtriCure reports preliminary results for fourth quarter and full year 2018
Nov 01,2018 Atricure reports third quarter 2018 financial results
Aug 01,2018 Atricure reports second quarter 2018 financial results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
AtriCure Inc – Key Facts
AtriCure Inc – Key Employees
AtriCure Inc – Key Employee Biographies
AtriCure Inc – Major Products and Services
AtriCure Inc – History
AtriCure Inc – Company Statement
AtriCure Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
AtriCure Inc – Business Description
Geographical Segment: Asia
Performance
Geographical Segment: Europe
Performance
Geographical Segment: Other international
Performance
Geographical Segment: the US
Performance
R&D Overview
AtriCure Inc – Corporate Strategy
AtriCure Inc – SWOT Analysis
SWOT Analysis – Overview
AtriCure Inc – Strengths
AtriCure Inc – Weaknesses
AtriCure Inc – Opportunities
AtriCure Inc – Threats
AtriCure Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
AtriCure Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019
AtriCure Inc, Medical Equipment, Deals By Type, 2013 to YTD 2019
AtriCure Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 28, 2019: AtriCure reports fourth quarter and full year 2018 financial results
Jan 07, 2019: AtriCure reports preliminary results for fourth quarter and full year 2018
Nov 01, 2018: Atricure reports third quarter 2018 financial results
Aug 01, 2018: Atricure reports second quarter 2018 financial results
Jun 05, 2018: AtriCure and Baheal Group Establish Partnership and China Distribution Agreement
Apr 26, 2018: AtriCure Reports First Quarter 2018 Financial Results
Feb 26, 2018: AtriCure Announces Fourth Quarter and Full Year 2017 Financial Results
Feb 20, 2018: AtriCure Names Scott Drake Board Chairman
Jan 08, 2018: AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2017
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
AtriCure Inc, Key Facts
AtriCure Inc, Key Employees
AtriCure Inc, Key Employee Biographies
AtriCure Inc, Major Products and Services
AtriCure Inc, History
AtriCure Inc, Other Locations
AtriCure Inc, Subsidiaries
AtriCure Inc, Key Competitors
AtriCure Inc, Ratios based on current share price
AtriCure Inc, Annual Ratios
AtriCure Inc, Annual Ratios (Cont...1)
AtriCure Inc, Interim Ratios
AtriCure Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019
AtriCure Inc, Medical Equipment, Deals By Type, 2013 to YTD 2019
AtriCure Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
AtriCure Inc, Performance Chart (2014 - 2018)
AtriCure Inc, Ratio Charts
AtriCure Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019
AtriCure Inc, Medical Equipment, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[AtriCure Inc (ATRC):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sangamo Therapeutics Inc (SGMO)-製薬・医療分野:企業M&A・提携分析
    Summary Sangamo Therapeutics Inc (Sangamo), formerly Sangamo BioSciences Inc, is a clinical stage biopharmaceutical company which focuses on the research and development and commercialization of engineered DNA-binding proteins (ZFPs) for gene regulation and therapeutic genome editing. The company is …
  • RTL Group S.A. (00007453):企業の財務・戦略的SWOT分析
    RTL Group S.A. (00007453) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Denbury Resources Inc.:企業の戦略・SWOT・財務情報
    Denbury Resources Inc. - Strategy, SWOT and Corporate Finance Report Summary Denbury Resources Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Arzeda Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Arzeda Corp (Arzeda) is a biotechnology company that develops biological solutions for transformative products. The company’s products include novel crop traits, 1, 3-butadiene, levulinic acid, and methane. Its services comprise enzyme design, metabolic engineering, and protein optimization …
  • The Chugoku Electric Power Co., Inc.:企業の戦略・SWOT・財務情報
    The Chugoku Electric Power Co., Inc. - Strategy, SWOT and Corporate Finance Report Summary The Chugoku Electric Power Co., Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Kuwait And Middle East Financial Investment Company (K.S.C.P.) (KMEFIC):企業の財務・戦略的SWOT分析
    Kuwait And Middle East Financial Investment Company (K.S.C.P.) (KMEFIC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view …
  • Vergnet SA (ALVER):企業の財務・戦略的SWOT分析
    Vergnet SA (ALVER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Relievant MedSystems Inc:医療機器:M&Aディール及び事業提携情報
    Summary Relievant MedSystems Inc (Relievant) is a medical device company developing new minimally-invasive solutions for the treatment of chronic low back pain (CLBP). The company's Intracept system, a minimally invasive procedure uses radiofrequency energy delivered through a small access tube into …
  • Landauer Inc (LDR):企業の財務・戦略的SWOT分析
    Summary Landauer Inc (Landauer), a subsidiary of Fortive Corp, is a medical device company that manufactures and distributes integrated radiation safety products. The company provides professional medical physics, occupational radiation monitoring, and medical products. Its products include dosimete …
  • Fondazione Telethon:製薬・医療:M&Aディール及び事業提携情報
    Summary Fondazione Telethon (Telethon) is a non-profit healthcare organization that funds and invests for projects in the area of biomedical research on genetic diseases. The organization develops projects by offering support services for increasing the horizons of therapeutic application to new res …
  • PT Sun Life Financial Indonesia:企業の戦略・SWOT・財務情報
    PT Sun Life Financial Indonesia - Strategy, SWOT and Corporate Finance Report Summary PT Sun Life Financial Indonesia - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • LifeLabs Inc:医療機器:M&Aディール及び事業提携情報
    Summary LifeLabsInc (LifeLabs), formerly MDS Diagnostic Services is a laboratory service provider that diagnoses, treats, monitors and prevent diseases in patients. The laboratory's services include clinical studies and services, drug and alcohol screening, employee wellness, hospital lab services, …
  • Advanced Info Service PLC (ADVANC):企業の財務・戦略的SWOT分析
    Advanced Info Service PLC (ADVANC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Kazakhtelecom (KZTK):企業の財務・戦略的SWOT分析
    Kazakhtelecom (KZTK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Cryosite Ltd (CTE):企業の財務・戦略的SWOT分析
    Summary Cryosite Ltd (Cryosite) is a healthcare solution provider that offers clinical trials outsourced logistics services to research, medical, pharmaceutical, veterinary and biotechnology industries. The company manufactures stem cell products for both therapeutic use and clinical trials. It prov …
  • Leonardo UK Ltd:企業の戦略・SWOT・財務情報
    Leonardo UK Ltd - Strategy, SWOT and Corporate Finance Report Summary Leonardo UK Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Ultra Clean Holdings Inc (UCTT):企業の財務・戦略的SWOT分析
    Summary Ultra Clean Holdings Inc (UCH) is a developer and supplier of critical systems and subsystems. The company’s products include precision robotic solutions, gas delivery systems, industrial and automation production equipment, chemical delivery modules, top-plate assemblies, wafer cleaning sub …
  • The Nisshin OilliO Group, Ltd.:企業の戦略・SWOT・財務分析
    The Nisshin OilliO Group, Ltd. - Strategy, SWOT and Corporate Finance Report Summary The Nisshin OilliO Group, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Sensimed AG-医療機器分野:企業M&A・提携分析
    Summary Sensimed AG (Sensimed) is a medical device company that offers soft contact lens-based solutions. The company’s products comprise Sensimed Triggerfish, a non-invasive soft contact lens-based solution designed for the overall management of glaucoma. It offers automated recording of continuous …
  • Sigma Pharmaceuticals Limited:戦略・SWOT・企業財務分析
    Sigma Pharmaceuticals Limited - Strategy, SWOT and Corporate Finance Report Summary Sigma Pharmaceuticals Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆